2-(Propane-1-sulfonyl)benzene-1-sulfonyl chloride | 89265-36-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(Propane-1-sulfonyl)benzene-1-sulfonyl chloride
• 英文别名: 2-propylsulfonylbenzenesulfonyl chloride
• CAS: 89265-36-1
• 化学式: C₉H₁₁ClO₄S₂
• 分子量: 282.8
• InChiKey: BAIVBJBDOPOXTD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  85
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS
  申请人：CARDIOXYL PHARMACEUTICALS

  公开号：US20150366977A1

  公开（公告）日：2015-12-24

  The present disclosure provides nitroxyl donating pharmaceutical compositions comprising N-substituted hydroxylamine derivatives. The compositions are highly efficacious in treating cardiovascular diseases (e.g., heart failure), have a suitable toxicological profile, and are sufficiently stable for intravenous or oral administration.

  本公开提供了含有N-取代羟胺衍生物的亚硝酰基供体药物组合物。该组合物在治疗心血管疾病（如心力衰竭）方面具有高效性，具有适当的毒理学特性，并且对于静脉或口服给药具有足够的稳定性。
• Process for the nucleophilic substitution of unactivated aromatic and heteroaromatic substrates
  申请人：E.I. DU PONT DE NEMOURS AND COMPANY

  公开号：EP0094821A1

  公开（公告）日：1983-11-23

  A process for achieving nucleophilic substitution upon an unactivated monocyclic or polycyclic aromatic or heteroaromatic substrate bearing a suitable leaving group comprising the substitution of said leaving group by an anionic nucleophile is catalyzed with a cyclic or acyclic polydentate chelating ligand, e.g. a crown ether or a cyclic polyether. The process is applicable, inter alia, as the first step in the preparation of ortho-substituted benzenesulfonyl chloride derivatives, or ortho-benzenedithiol, from ortho-dichlorobenzene.

  一种在带有适当离去基团的未活化单环或多环芳香族或杂芳族底物上实现亲核取代的工艺，包括在环状或无环多齿螯合配体（例如冠醚或环状聚醚）的催化下用阴离子亲核剂取代所述离去基团。该工艺尤其适用于从邻二氯苯制备邻取代苯磺酰氯衍生物或邻苯二硫醇的第一步。
• Pharmaceutical compositions comprising nitroxyl donors
  申请人：Cardioxyl Pharmaceuticals, Inc.

  公开号：US10245249B2

  公开（公告）日：2019-04-02

  The present disclosure provides nitroxyl donating pharmaceutical compositions comprising N-substituted hydroxylamine derivatives. The compositions are highly efficacious in treating cardiovascular diseases (e.g., heart failure), have a suitable toxicological profile, and are sufficiently stable for intravenous or oral administration.

  本公开提供了由 N-取代的羟胺衍生物组成的硝基捐献药物组合物。这些组合物在治疗心血管疾病（如心力衰竭）方面疗效显著，具有合适的毒理学特征，并且足够稳定，可用于静脉注射或口服给药。
• EP3427728A1
  申请人：——

  公开号：EP3427728A1

  公开（公告）日：2019-01-16
• US4683091A
  申请人：——

  公开号：US4683091A

  公开（公告）日：1987-07-28